Targeting the epidermal growth factor receptor: an important incremental step in the battle against colorectal cancer
- PMID: 14993229
- DOI: 10.1200/JCO.2004.01.971
Targeting the epidermal growth factor receptor: an important incremental step in the battle against colorectal cancer
Comment on
-
Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.J Clin Oncol. 2004 Apr 1;22(7):1201-8. doi: 10.1200/JCO.2004.10.182. Epub 2004 Mar 1. J Clin Oncol. 2004. PMID: 14993230 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials